UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|
| |||
(State or other jurisdiction |
| (Commission |
| (IRS Employer |
(Address of principal executive offices, including Zip Code)
Registrant’s telephone number, including area code: (
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading |
| Name of each exchange |
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 | Submission of Matters to a Vote of Security Holders. |
Coherus BioSciences, Inc. (the “Company”) held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”) on June 7, 2023 virtually via the Internet. At the close of business on April 10, 2023, the record date, there were 80,542,826 shares of the Company’s common stock outstanding with each such share being entitled to one vote per share.
At the Annual Meeting, 65,906,316 shares of the Company’s common stock were voted in person or by proxy for the three proposals set forth below, each of which is described in the Company’s Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 17, 2023.
Proposal 1. The Company’s stockholders elected by a majority of votes cast both of the Class III director nominees below, Dennis M. Lanfear and Mats L. Wahlström, to the Board to hold office until the 2026 annual meeting of stockholders or until their successors are elected.
BROKER | ||||||||
NOMINEE | FOR | WITHHELD | NON- | |||||
VOTES | ||||||||
Dennis M. Lanfear | 57,378,374 | 1,424,977 | 7,102,965 | |||||
Mats L. Wahlström | 42,646,152 | 16,157,199 | 7,102,965 |
Proposal 2. The Company’s stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2023.
BROKER | ||||||
FOR | AGAINST | ABSTAIN | NON-VOTES | |||
65,375,866 | 434,987 | 95,463 | 0 |
Proposal 3. The Company’s stockholders approved a non-binding, advisory resolution to approve the compensation of the Company’s named executive officers (a “Say-on-Pay” vote).
BROKER | ||||||
FOR | AGAINST | ABSTAIN | NON-VOTES | |||
55,379,513 | 3,233,870 | 189,968 | 7,102,965 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: June 9, 2023 |
| COHERUS BIOSCIENCES, INC. | |
By: | /s/ McDavid Stilwell | ||
Name: | McDavid Stilwell | ||
Title: | Chief Financial Officer |
Document and Entity Information |
Jun. 07, 2023 |
---|---|
Document and Entity Information | |
Entity Registrant Name | COHERUS BIOSCIENCES, INC. |
Document Type | 8-K |
Securities Act File Number | 001-36721 |
Entity Tax Identification Number | 27-3615821 |
Document Period End Date | Jun. 07, 2023 |
Entity Address, Address Line One | 333 Twin Dolphin Drive, |
Entity Address, Address Line Two | Suite 600 |
Entity Address, Postal Zip Code | 94065 |
City Area Code | 650 |
Local Phone Number | 649-3530 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Issuer Tender Offer | false |
Pre-commencement Tender Offer | false |
Amendment Flag | false |
Title of 12(b) Security | Common Stock, $0.0001 par value per share |
Trading Symbol | CHRS |
Security Exchange Name | NASDAQ |
Entity Incorporation, State or Country Code | DE |
Entity Address, City or Town | Redwood City, |
Entity Address, State or Province | CA |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001512762 |
F;T0N.AFDX7+5'^V$2P;P8"X30[''\K.58N''R'O$%F\1:YY727Q-O^KI>
M2,0_TH!(06*E0BPUHN \)KZY6D^^YCB6!C$:?4Q,R3GGSC5]3#G$#AO8D27'
M2TP\A4HC\+_=<&HW^%/&E?]HJG?.]5/XJ:.V@\!M#=3'/2S+[CN4"/!569*F
MP+\WTZ3@4GSL,]5 R' P$?PPRI( !/W$]KJ;P$) $@H18]W;?48VG>WR,J@<
MW0!!Y%A<\)^,M[:"M^J.9>H8RW;['(MQ+,NM!&/UN^[ +XS'72[H"7^JE;OO
MM>_]8<98\6"FP .]"'H/N8J7(,,+"<::V $+4T3J>MTOO*PQ6^/E;7"N
M^:B'Y1PY4/Y%KK77D 22X1LT5^+=ZD[/@FH\:U+ P[8DY011SBOS0JYP%,F2D]_2$RQ;3C*?A%36G
M%I6,#M]]%;59=+@PX3V>T"@+K-F>@(MEHV_#!I*A:.T'DJ%H[0>RA!Q-Q$.W
M\6-XQ2!"GV#"JZA;"+I$+^E$78O/'1%)%U?K[GV]__;?_YKQD$X(G03W.6XI
M5I@2@XQ,)0*=1]N("1VPL(6UG!*TAG#L18.6579R%DMIHG,1J ">8\7"?T'B
M]]3IFN@."1Q, ' F=C!Z;39\,+[YC",XPA.9_M<=28\1VBQ@YHT7 M/XLM/D
M#4TJJBVYJ7,BUY0*NMY4H